ST LUKES PRIMARY CARE CENTRE — All Prescriptions & Medications — Page 14
Practice Code: K83041 | NORTHAMPTON, NN5 6FR
Showing results 651-700 of 772
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Phosphates (Rectal) | 15 | 105 | £3.6K | +22.7% ▲ |
| Ipratropium bromide | 15 | 1,616 | £407 | -47.8% ▼ |
| Fluvoxamine maleate | 15 | 801 | £435 | +23.4% ▲ |
| Dexamfetamine sulfate | 15 | 428 | £331 | -58.3% ▼ |
| Tapentadol | 15 | 2,324 | £1.0K | -63.6% ▼ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913051) | 15 | 98.0K | £2.2K | +71.5% ▲ |
| Ready to serve infant formula, high energy (0913104) | 15 | 109.4K | £1.6K | +35.8% ▲ |
| Loteprednol etabonate | 15 | 75 | £79 | +62.2% ▲ |
| Cocois | 15 | 1,040 | £191 | +9.2% ▲ |
| 15 | 190 | £334 | -42.1% ▼ | |
| 15 | 2,425 | £210 | -11.2% ▼ | |
| Salbutamol | 14 | 840 | £321 | +108.5% ▲ |
| Promazine hydrochloride | 14 | 2,100 | £1.1K | -73.5% ▼ |
| Phenobarbital | 14 | 784 | £23 | -54.5% ▼ |
| Safinamide | 14 | 420 | £918 | -30.5% ▼ |
| Metyrapone | 14 | 392 | £1.7K | +76.7% ▲ |
| Clindamycin phosphate | 14 | 600 | £155 | +235.6% ▲ |
| Vardenafil | 14 | 112 | £235 | +0.3% vs avg |
| Magnesium glycerophosphate | 14 | 1,400 | £602 | +1.9% vs avg |
| RtS 1.5 kcal/g dessert style (milk based) (0913021) | 14 | 56.4K | £1.4K | +71.6% ▲ |
| 14 | 183.4K | £3.3K | +54.4% ▲ | |
| Tube feed 1 kcal/ml peptide based (0914041) | 14 | 394.0K | £12.5K | +57.5% ▲ |
| Nepafenac | 14 | 70 | £199 | +125.4% ▲ |
| Apraclonidine | 14 | 70 | £145 | +11.1% ▲ |
| Triamcinolone acetonide | 14 | 14 | £98 | +36.6% ▲ |
| Dimeticone (Barrier) | 14 | 700 | £63 | -4.8% ▼ |
| Azelaic acid | 14 | 450 | £93 | -41.4% ▼ |
| 14 | 320 | £262 | +111.4% ▲ | |
| 14 | 33 | £361 | +60.3% ▲ | |
| 14 | 1,050 | £199 | -37.4% ▼ | |
| 14 | 480 | £1.2K | -25.0% ▼ | |
| 14 | 980 | £1.8K | +61.4% ▲ | |
| 14 | 420 | £2.6K | +21.7% ▲ | |
| Torasemide | 13 | 364 | £165 | +15.8% ▲ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 13 | 364 | £164 | -20.5% ▼ |
| Propafenone hydrochloride | 13 | 1,170 | £112 | +20.1% ▲ |
| Captopril | 13 | 728 | £242 | -10.2% ▼ |
| Eprosartan | 13 | 364 | £90 | -35.6% ▼ |
| Fluticasone furoate/vilanterol | 13 | 21 | £475 | -91.6% ▼ |
| Roflumilast | 13 | 390 | £466 | -1.0% vs avg |
| Desloratadine | 13 | 390 | £35 | -54.9% ▼ |
| Doxepin | 13 | 364 | £958 | +0.0% vs avg |
| Agomelatine | 13 | 728 | £307 | -26.6% ▼ |
| Orlistat | 13 | 1,092 | £260 | -84.2% ▼ |
| Felbamate | 13 | 1,780 | £13.6K | -1.9% vs avg |
| Perampanel | 13 | 364 | £1.7K | -40.0% ▼ |
| Lamivudine | 13 | 364 | £1.0K | +64.9% ▲ |
| Valaciclovir | 13 | 710 | £905 | -7.5% ▼ |
| Raloxifene hydrochloride | 13 | 364 | £52 | -12.0% ▼ |
| Other phosphate supplement preparations | 13 | 980 | £186 | +113.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.